title: The best way to prevent cytomegalovirus infection after liver transplantation: the debate goes on.
authors.affiliation: Department of Hepatology & Gastroenterology, Erasmus MC, University Hospital Rotterdam, Rotterdam, the Netherlands. h.j.metselaar@erasmusmc.nl
authors.forename: Herold J
authors.initials: HJ
authors.lastname: Metselaar
authors.forename: Margo J H
authors.initials: MJ
authors.lastname: van Campenhout
authors.forename: Annemiek A
authors.initials: AA
authors.lastname: van der Eijk
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D005260:Female; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D009894:Opportunistic Infections / Q000517:prevention & control*; D000077562:Valganciclovir; D014766:Viremia / Q000517:prevention & control*
chemical_list: D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir